Hematology

Researchers believe drug will lead to ‘new paradigm' in leukemia therapy.

Scalp cooling technology seeks to ensure hair retention in most instances.

Costs have risen 120% in aggregate since 1995.

Study finds depression in African American cancer patients has gone under-recognized.

Compound can monitor biochemical processes involved with protein kinases.

Celgene today announced that the FDA has granted an expanded use approval for its multiple myeloma drug, lenalidomide (Revlimid).

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.

Efficacy and safety demonstrated in models of aggressive leukemia.

Expanded indication would include patients with relapsed multiple myeloma who received prior therapy.

Phase 3 trial for polycythemia vera drug significantly improved hematocrit control without the need for phlebotomy.

Chimeric antigen receptor may be able to treat a number of cancer types.

Pharmacists can play a vital role by finding financial aid through foundations and co-pay programs.

Government office cuts 16 drugs amid funding problems.

Targeted therapy found to shrink tumor growth.

The FDA today granted orphan drug designation to an experimental drug that treats several types of blood cancers.

Drug found to be as effective as current treatment without serious side effects.

Carfilzomib added to 2-drug combination produces longer remission period.

Adding a building block found in DNA could aid healthy cell production in cancer patients, study finds.

Priced at approximately $178,000 for 2 courses of treatment, Blincyto will be one of the most expensive cancer medications on the market.

FL118 could be effective in treating late stage cancers.

Actimab-A is an alpha radiolabeled antibody in development for newly diagnosed acute myeloid leukemia patients over the age of 60.

Active substance overcomes treatment resistance in Philadelphia chromosome-positive leukemia.

Alcohol use is responsible for an estimated 3.5% of cancers in the United States, but affects the risk of developing some cancers more than others.

Oral drug combination effective in treating newly diagnosed multiple myeloma.